A regional voice
for eye health.
BAREEQ is a bilingual glaucoma awareness initiative, in partnership with Jamjoom Pharma, dedicated to early detection, education and ongoing support for people affected by the silent thief of sight.
A world where no one
loses sight to glaucoma.

Bridging clinical research and the people who need it most.
BAREEQ was founded to translate complex medical knowledge into clear, action-ready guidance — in both English and Arabic. We work alongside ophthalmologists, hospitals, patient advocates and pharmaceutical partners to make eye health accessible to everyone.
Glaucoma affects more than 80 million people worldwide and is the second leading cause of blindness. Half of those affected don't know they have it. Our role is to change that — through screening days, webinars, education and community support.
“Every person who books a screening because of BAREEQ is a victory against the silent thief.”Get in touch →
What we stand for.
Three principles guide every screening, every webinar and every word we publish.
Compassion
Every visitor is someone navigating fear or a new diagnosis. We meet them with empathy, never jargon.
Accuracy
All content is reviewed by certified ophthalmologists before publication. No shortcuts, no speculation.
Accessibility
Bilingual, mobile-first, screen-reader friendly. Eye health information that's truly available to all.
Numbers that matter.
Since launching, BAREEQ has helped thousands of people take the first step toward saving their sight.
The people behind BAREEQ.
Specialists, advocates and creators united by one mission.
Medical Advisory
A board of practicing ophthalmologists who review every piece of clinical content before it's published.
Patient Advocates
People living with glaucoma who shape our programs and ensure we serve real needs, not assumptions.
Education Team
Bilingual writers, designers and translators who turn medicine into clarity — in English and Arabic.
Become part of the mission.
Whether you want to volunteer, partner with us, or share your story — we'd love to hear from you.
Get In Touch →